Quantcast
Channel: Health Care RSS Feed
Viewing all articles
Browse latest Browse all 24638

22nd Century expands focus on cannabis through subsidiary

$
0
0
A Clarence biotechnology firm is expanding its cannabis subsidiary with an eye toward participating in the medical marijuana program here in New York and elsewhere. Botanical Genetics LLC , a wholly-owned subsidiary of 22nd Century Group Inc. (NYSE MKT: XXII), will focus on developing proprietary cannabis strains for medical applications, and developing very low THC industrial hemp that may be legally grown in the U.S. and around the world as a commercial agricultural crop. It’s the next step…

Viewing all articles
Browse latest Browse all 24638

Trending Articles